European health systems are jeopardizing efforts to strengthen the local supply chain and bolster manufacturing in the region by opting for the lowest-cost generics rather than considering important non-price factors, according to Christoph Stoller, president of off-patent industry association Medicines for Europe.
Speaking at an event held by German body ProGenerika – during the German presidency of the Council of the EU,...